BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 26, 2007
View Archived Issues
MEK inhibitor potentiates dasatinib-induced apoptosis of CML cells
Read More
New therapeutic agents for cancer imparted in recent patents
Read More
Phase II study of MKC-1 in advanced breast cancer cleared to continue
Read More
Transtec provides reliable analgesia in cancer pain patients
Read More
Recent Uriach and ProMetic patents impart novel treatments for immune and autoimmune disorders
Read More
Recent Hammersmith Imanet patent discloses novel diagnostic agents
Read More
NNZ-2566 is safe in phase I study
Read More
Actemra demonstrates significant improvement in signs and symptoms of RA
Read More
Preclinical characterization of SSR-180711, a novel selective alpha7 nAChRr partial agonist
Read More
GlaxoSmithKline reports on melanocortin 4 receptor agonists as novel antiobesity compounds
Read More
Novel nonpeptide GLP-1 receptor agonist exhibits antidiabetic efficacy in vivo
Read More
Intranasal insulin improves memory
Read More
BioProgress updates drug development progress
Read More
New trial evaluates oral cladribine with Rebif for MS
Read More
Renovis announces restructuring plan
Read More
Cell Therapeutics makes unsolicited offer for DOR BioPharma
Read More
LX-1031 begins phase I trials for IBS and GI disorders
Read More
Molecular Insight acquires radiotherapy candidate Onalta
Read More
ADX-10061 begins proof-of-concept study for smoking cessation
Read More
Avontec and Activaero sign development deal for inhaleable AVT01
Read More
New phase II trial studies OBE-101 for weight loss in obese patients
Read More
Barrow receives grant to support neurofibromatosis research
Read More
Kirin and Astellas collaborate on anti-CD40 antagonistic MAb
Read More
Suboxone available in U.K.
Read More
Toyama seeks clearance to begin U.S. studies of T-705
Read More
Irinotecan eluting beads safe and effective in GI cancers
Read More